One of Kalorama's best-selling market research reports, this report provides the reader with a complete analysis of the domestic and international markets for pharmaceuticals to treat skin diseases and disorders. This edition of Worldwide Market for Prescription Dermatological Drugs is the sixth time Kalorama Information has comprehensively studied the dermatology markets.

Kalorama has completely re-evaluated the market from the ground up, and in addition to the usual primary research (interviews) of industry participants, clinicians, and regulators, we also conducted scores of interviews with users of Kalorama’s 2004 and 2006 dermatological studies to ensure that the current report contains the best possible data and the most useful analysis.

In this new edition, various shifts in the market are noted. There is information on bilogics, discussion of fillers and of treatments for skin infections such as MRSA. New companies have been added and consolidations in the industry have been addressed.

Market information is available for the years 2004 to 2011, with the focus year 2006 for competitive analysis. Overview and product descriptions of general therapy segments are covered, including prescription drugs to treat:

• Acne and Rosacea
• Antiaging and Photodamage
• Dermatitis and Seborrhea
• Fungal Infections
• Hair Loss and Hair Removal
• Hyperpigmentation/Melasma
• Psoriasis
• Skin Cancer, and
• Other Skin Disorders

Other data points include competitive market share, demographics, epidemiology, and geographic break down, which provide revenues for four regions:

• United States
• Europe
• Japan
• Rest of world

The study covers issues and trends affecting the market, research and developments, and more. In particular, the study explores the current and potential effects of the aging baby boomers on the prescription dermatology market and the continued demand for lifestyle drugs. Profiles of major market participants are included, including:

• Allergan Inc.
• Allergan Inamed Corporation
• Barrier Therapeutics, Inc
• Bayer AG
• Bradley Pharmaceuticals, Inc
• Bristol-Myers Squibb
• CollaGenex Pharmaceuticals
• Galderma S.A.
• Genentech, Inc.
• GlaxoSmithKline Plc
• Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil)
• Medicis Pharmaceutical Corporation
• Merck & Company, Inc.
• Mylan Pharmaceuticals, Inc,
• Novartis Pharmaceuticals Corporation
• Nycomed Inc.
• Pfizer, Inc.
• Q-Med AB
• Roche Group (F. Hoffmann-La Roche Ltd.)
• Schering-Plough Corporation
• Sinclair Pharma Plc.
• SkinMedica
• Stiefel Laboratories, Inc.
• Valeant Pharmaceuticals, Inc.

Related Reports:

Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products
Nov 1, 2008 - KLI1816262 - $3,995.00

Glucose Testing Markets
Nov 1, 2008 - KLI1911068 - $1,995.00

Smoking Cessation: World Markets
Nov 1, 2008 - KLI1646594 - $3,500.00

Worldwide In Vitro Diagnostics Market Research Bundle (Worldwide Market for In Vitro Diagnostic Tests, SNP Genotyping Markets, Companion Diagnostics, Testing Services Markets)
Oct 1, 2008 - KLI1927625 - $7,995.00

HIV: Markets for Diagnostics and Therapeutics
Oct 1, 2008 - KLI1646600 - $3,500.00

Kalorama Medical Device Market Research Bundle: Infusion Pumps, Minimally Invasive Devices, Syringes, Hip and Knee Implants, Respiratory Equipment, Asian Device Markets, OEM Contract Manufacturing, Reusable Equipment, Catheters)
Oct 1, 2008 - KLI1927457 - $9,995.00

Minimally Invasive Surgical Devices, World Market
Sep 1, 2008 - KLI1614100 - $3,500.00

Facial Rejuvenation Markets Worldwide
Aug 1, 2008 - KLI1190879 - $3,500.00

IVD Market Research Supplement : Testing Services Markets, SNP Analysis, DNA Sequencing, Retail Clinics, Companion Diagnostics
Aug 1, 2008 - KLI1836320 - $8,995.00

World Market for Respiratory Equipment and Disposables, 3rd. Edition
Aug 1, 2008 - KLI1676679 - $2,995.00